Up a level |
Menzies, Stefanie K ORCID: 0000-0002-9273-9296, Arinto-Garcia, Raquel, Amorim, Fernanda Gobbi, Cardoso, Iara Aimê, Abada, Camille, Crasset, Thomas, Durbesson, Fabien, Edge, Rebecca J, El-Kazzi, Priscila, Hall, Sophie et al (show 12 more authors)
(2023)
ADDovenom: Thermostable Protein-Based ADDomer Nanoparticles as New Therapeutics for Snakebite Envenoming.
Toxins, 15 (12).
p. 673.
Solano, Gabriela, Cunningham, Sinead, Edge, Rebecca J ORCID: 0000-0001-8574-3724, Duran, Gina, Sanchez, Adriana, Villalta, Mauren, Clare, Rachel H, Wilkinson, Mark C, Marriott, Amy E ORCID: 0000-0002-4806-9539, Abada, Camille et al (show 8 more authors)
(2024)
African polyvalent antivenom can maintain pharmacological stability and ability to neutralise murine venom lethality for decades post-expiry: evidence for increasing antivenom shelf life to aid in alleviating chronic shortages.
BMJ global health, 9 (3).
e014813-e014813.
Kazandjian, Taline D ORCID: 0000-0002-5383-0505, Arrahman, Arif, Still, Kristina BM, Somsen, Govert W, Vonk, Freek J, Casewell, Nicholas R, Wilkinson, Mark C and Kool, Jeroen
(2021)
Anticoagulant Activity of <i>Naja nigricollis</i> Venom Is Mediated by Phospholipase A2 Toxins and Inhibited by Varespladib.
TOXINS, 13 (5).
302-.
Abouyannis, Michael, Aggarwal, Dinesh, Lalloo, David G ORCID: 0000-0001-7680-2200, Casewell, Nicholas R, Hamaluba, Mainga and Esmail, Hanif
(2021)
Clinical outcomes and outcome measurement tools reported in randomised controlled trials of treatment for snakebite envenoming: A systematic review.
PLOS NEGLECTED TROPICAL DISEASES, 15 (8).
e0009589-.
Arbuckle, Kevin ORCID: 0000-0002-9171-5874, de la Vega, Ricardo C Rodriguez and Casewell, Nicholas R
(2017)
Coevolution takes the sting out of it: Evolutionary biology and mechanisms of toxin resistance in animals.
TOXICON, 140.
pp. 118-131.
Arrahman, Arif, Kazandjian, Taline D ORCID: 0000-0002-5383-0505, Still, Kristina BM, Slagboom, Julien, Somsen, Govert W, Vonk, Freek J, Casewell, Nicholas R and Kool, Jeroen
(2022)
A Combined Bioassay and Nanofractionation Approach to Investigate the Anticoagulant Toxins of Mamba and Cobra Venoms and Their Inhibition by Varespladib.
TOXINS, 14 (11).
736-.
Tianyi, Frank-Leonel, Hamza, Muhammad, Abubakar, Saidu B, Al Solaiss, Jaffer, Trelfa, Anna, Abdullahi, Hadiza L, Iliyasu, Garba, Mohammed, Nuhu, Mohammed, Suleman A, Casewell, Nicholas R et al (show 4 more authors)
(2023)
Diagnostic characteristics of the 20-minute whole blood clotting test in detecting venom-induced consumptive coagulopathy following carpet viper envenoming.
PLOS NEGLECTED TROPICAL DISEASES, 17 (6).
e0011442-.
Alomran, Nessrin, Blundell, Patricia, Alsolaiss, Jaffer, Crittenden, Edouard, Ainsworth, Stuart, Dawson, Charlotte A, Edge, Rebecca J, Hall, Steven R ORCID: 0000-0001-5314-4970, Harrison, Robert A, Wilkinson, Mark C et al (show 2 more authors)
(2022)
Exploring the Utility of Recombinant Snake Venom Serine Protease Toxins as Immunogens for Generating Experimental Snakebite Antivenoms.
TOXINS, 14 (7).
443-.
Menzies, Stefanie K ORCID: 0000-0002-9273-9296, Clare, Rachel H, Xie, Chunfang, Westhorpe, Adam, Hall, Steven R ORCID: 0000-0001-5314-4970, Edge, Rebecca J, Alsolaiss, Jaffer, Crittenden, Edouard, Marriott, Amy E, Harrison, Robert A et al (show 2 more authors)
(2022)
In vitro and in vivo preclinical venom inhibition assays identify metalloproteinase inhibiting drugs as potential future treatments for snakebite envenoming by Dispholidus typus.
Toxicon: X, 14.
p. 100118.
Albulescu, Laura-Oana, Westhorpe, Adam, Clare, Rachel H, Woodley, Christopher M, James, Nivya, Kool, Jeroen, Berry, Neil G ORCID: 0000-0003-1928-0738, O'Neill, Paul M and Casewell, Nicholas R
(2023)
Optimizing drug discovery for snakebite envenoming via a high-throughput phospholipase A2 screening platform.
Frontiers in pharmacology, 14.
p. 1331224.
Kazandjian, Taline D ORCID: 0000-0002-5383-0505, Hamilton, Brett R, Robinson, Samuel D, Hall, Steven R, Bartlett, Keirah E ORCID: 0000-0003-3497-1385, Rowley, Paul, Wilkinson, Mark C, Casewell, Nicholas R and Undheim, Eivind AB
(2022)
Physiological constraints dictate toxin spatial heterogeneity in snake venom glands.
BMC BIOLOGY, 20 (1).
148-.
Clare, Rachel H, Dawson, Charlotte A, Westhorpe, Adam, Albulescu, Laura-Oana, Woodley, Christopher M, Mosallam, Nada, Chong, Daniel JW, Kool, Jeroen, Berry, Neil G ORCID: 0000-0003-1928-0738, O’Neill, Paul M et al (show 1 more authors)
(2024)
Snakebite drug discovery: high-throughput screening to identify novel snake venom metalloproteinase toxin inhibitors.
Frontiers in Pharmacology, 14.
1328950-.
Padidar, Sara ORCID: 0000-0003-2769-210X, Monadjem, Ara, Litschka-Koen, Thea, Thomas, Brent, Shongwe, Nondusimo, Baker, Clare, Mmema, Lindelwa, Sithole, Trevor, Murray, James, Casewell, Nicholas R et al (show 5 more authors)
(2023)
Snakebite epidemiology, outcomes and multi-cluster risk modelling in Eswatini.
PLoS neglected tropical diseases, 17 (11).
e0011732-.
Tianyi, Frank-Leonel, Oluoch, George O, Otundo, Denis, Ofwete, Robert, Ngari, Cecilia, Trelfa, Anna, Ahmed, Sayem, Wang, Duolao, Smith, Monica, Meta, Viviane et al (show 4 more authors)
(2024)
Snakebite prevalence and risk factors in a nomadic population in Samburu County, Kenya: A community-based survey.
PLoS neglected tropical diseases, 18 (1).
e0011678-e0011678.
Abouyannis, Michael ORCID: 0000-0003-4856-4334, FitzGerald, Richard, Ngama, Mwanajuma, Mwangudzah, Hope ORCID: 0000-0003-1166-8965, Nyambura, Yvonne K, Ngome, Samson, Riako, Debra, Babu, Lawrence, Lewa, Frida, Else, Laura et al (show 10 more authors)
(2022)
TRUE-1: Trial of Repurposed Unithiol for snakebite Envenoming phase 1 (safety, tolerability, pharmacokinetics and pharmacodynamics in healthy Kenyan adults).
Wellcome open research, 7.
90-.
Menzies, Stefanie K ORCID: 0000-0002-9273-9296, Litschka-Koen, Thea, Edge, Rebecca J, Alsolaiss, Jaffer, Crittenden, Edouard, Hall, Steven R, Westhorpe, Adam, Thomas, Brent, Murray, James, Shongwe, Nondusimo et al (show 5 more authors)
(2022)
Two snakebite antivenoms have potential to reduce Eswatini's dependency upon a single, increasingly unavailable product: Results of preclinical efficacy testing.
PLOS NEGLECTED TROPICAL DISEASES, 16 (9).
e0010496-.
Menzies, Stefanie K ORCID: 0000-0002-9273-9296, Dawson, Charlotte A, Crittenden, Edouard, Edge, Rebecca J, Hall, Steven R, Alsolaiss, Jaffer, Wilkinson, Mark C, Casewell, Nicholas R, Harrison, Robert A and Ainsworth, Stuart
(2022)
Virus-like particles displaying conserved toxin epitopes stimulate polyspecific, murine antibody responses capable of snake venom recognition.
SCIENTIFIC REPORTS, 12 (1).
11328-.
Abouyannis, Michael, Esmail, Hanif, Hamaluba, Mainga, Ngama, Mwanajuma, Mwangudzah, Hope, Mumba, Noni, Yeri, Betty K, Mwalukore, Salim, Alphan, Hassan J, Aggarwal, Dinesh et al (show 16 more authors)
(2023)
A global core outcome measurement set for snakebite clinical trials.
LANCET GLOBAL HEALTH, 11 (2).
E296-E300.
Abouyannis, Michael, Boga, Mwanamvua, Amadi, David, Ouma, Nelson, Nyaguara, Amek, Mturi, Neema, Berkley, James A, Adetifa, Ifedayo M, Casewell, Nicholas R, Lalloo, David G ORCID: 0000-0001-7680-2200 et al (show 1 more authors)
(2023)
A long-term observational study of paediatric snakebite in Kilifi County, south-east Kenya.
PLoS neglected tropical diseases, 17 (7).
e0010987-e0010987.
Ainsworth, Stuart ORCID: 0000-0002-0199-6482, Slagboom, Julien, Alomran, Nessrin, Pla, Davinia, Alhamdi, Yasir, King, Sarah I, Bolton, Fiona MS, Gutierrez, Jose Maria, Vonk, Freek J, Toh, Cheng-Hock et al (show 4 more authors)
(2018)
The paraspecific neutralisation of snake venom induced coagulopathy by antivenoms.
COMMUNICATIONS BIOLOGY, 1 (1).
34-.
Albulescu, Laura-Oana, Xie, Chunfang, Ainsworth, Stuart, Alsolaiss, Jaffer, Crittenden, Edouard, Dawson, Charlotte A, Softley, Rowan, Bartlett, Keirah E ORCID: 0000-0003-3497-1385, Harrison, Robert A, Kool, Jeroen et al (show 1 more authors)
(2021)
A therapeutic combination of two small molecule toxin inhibitors provides broad preclinical efficacy against viper snakebite (vol 11, 6094, 2020).
NATURE COMMUNICATIONS, 12 (1).
4027-.